Page last updated: 2024-10-26

dimethadione and Liver Dysfunction

dimethadione has been researched along with Liver Dysfunction in 3 studies

Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.

Research Excerpts

ExcerptRelevanceReference
"Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic drug-oxidizing capacity in humans in vivo."2.39Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans. ( Abei, M; Ishikawa, A; Kobayashi, S; Tanaka, E, 1996)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, E3
Funae, Y1
Ishikawa, A2
Abei, M1
Kobayashi, S1
Ono, A1
Okamura, T1
Misawa, S1

Reviews

1 review available for dimethadione and Liver Dysfunction

ArticleYear
Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.
    Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology, 1996, Volume: 115, Issue:3

    Topics: Administration, Oral; Animals; Clinical Trials as Topic; Dimethadione; Humans; Liver Diseases; Micro

1996

Other Studies

2 other studies available for dimethadione and Liver Dysfunction

ArticleYear
Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity.
    Methods in enzymology, 1996, Volume: 272

    Topics: Animals; Anticonvulsants; Chromatography, Gas; Dimethadione; Humans; In Vitro Techniques; Liver; Liv

1996
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
    Journal of pharmacobio-dynamics, 1987, Volume: 10, Issue:9

    Topics: Carcinoma, Hepatocellular; Chronic Disease; Dimethadione; Female; Humans; Liver Cirrhosis; Liver Dis

1987